US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 31.795
  • -0.365-1.13%
Trading Mar 18 10:44 ET
1.77BMarket Cap24.09P/E (TTM)

Supernus Pharmaceuticals Key Stats

Supernus Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 25, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
155.25M
174.16M
+18.91M
Beat Est.
-5.52%
+5.99%
+12.18%
EPS
0
0.27
+0.27
Beat Est.
-100.00%
+1450.57%
--
Buy

Feb 28, 2025

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 154.219M--
--2025/Q1-- / 146.736M--
Feb 25, 20252024/Q4174.159M / 155.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 154.219M--
--2025/Q1-- / 146.736M--
Feb 25, 20252024/Q4174.159M / 155.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    40.00%
  • Hold

    60.00%
  • Sell

    0.00%

Price Target

No Data